Novus Therapeutics, Inc. Gains 35.71%
Thu, Jan 09, 2020 at 05:30 PM

Novus Therapeutics, Inc. (NVUS:NASDAQ) jumped higher at $0.95, a gain of 35.7%. On Wed 08 Jan 20, NVUS:NASDAQ touched a New 2-Week High of $0.7. From Tue 17 Dec 19, the stock recorded 42.86% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Novus Therapeutics, Inc. (NVUS:NASDAQ)
Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 122.84%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 93.96%
- Genetic Technologies Limited (GENE:NASDAQ), 45.09%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 36.53%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 35.71%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 34.96%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 34.71%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 33.59%
- KemPharm, Inc. (KMPH:NASDAQ), 31.72%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%